Alpha-GPC: Dosage, Benefits and Side Effects

Delivers choline across the blood-brain barrier more efficiently than choline bitartrate, raising acetylcholine synthesis. Acetylcholine matters for both memory formation and neuromuscular signalling, which is the rationale for its two very different uses.

• Mild cognitive impairment: a 2024 multicentre randomised trial in 100 subjects found 600 mg/day improved ADAS-cog scores by 2.34 points more than placebo over 12 weeks.
• Post-stroke cognitive recovery: a large Italian multicentre trial in 2,044 patients used 1,000 mg/day injected for 28 days then 1,200 mg/day orally for five months.
• Acute cognitive performance: improved Stroop scores in healthy trained men at 315 mg and 630 mg.
• Power output: small trials suggest an effect on force production; the evidence is thin next to the cognitive data.

A 2024 randomised double-blind placebo-controlled trial of 600 mg/day in amnestic mild cognitive impairment, Barbagallo Sangiorgi 1994 multicentre trial in 2,044 stroke and transient ischaemic attack patients, and a 2015 trial of alpha-GPC against caffeine and placebo on mood, cognition and power. The cognitive evidence is stronger and better replicated than the athletic evidence.

300-600 mg/day for cognitive use, the range the trials used. Pre-workout products typically use 300-600 mg taken 30-60 minutes before training. Splitting the dose is common but not required.

Headache, insomnia, dizziness, heartburn and GI upset at higher doses. Generally well tolerated in the trials, including the six-month post-stroke study.

Additive with other cholinergic agents including acetylcholinesterase inhibitors, where excess cholinergic activity can cause nausea and cramping. Anticholinergic drugs work against it. Some observational work has linked choline metabolites to cardiovascular risk via TMAO; the clinical significance for supplemental alpha-GPC is not settled and is worth mentioning to a prescriber if you have cardiovascular disease.